Clinical Trials
5 trialsNCT01371981 2026-06-02
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Completed
NCT02658487 2025-04-15
VITAL
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT02484391 2024-09-19
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
Wake Forest University Health Sciences
Phase 1 Completed
NCT05057299 2021-09-27
Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes
King Hussein Cancer Center
Completed
NCT01278069 2013-09-18
PETAML
Technische Universität Dresden
Completed